Global In-Vitro Diagnostics Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global In-Vitro Diagnostics market size will reach 77,985 Million USD in 2025 and is projected to reach 106,340 Million USD by 2032, with a CAGR of 4.53% (2025-2032). Notably, the China In-Vitro Diagnostics market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
In-Vitro Diagnostics (IVD) refers to a category of medical tests and diagnostic procedures that are performed on samples such as blood, urine, or tissue outside the body. These tests are designed to provide information about a patient's health status, identify specific diseases or conditions, and aid healthcare professionals in making accurate diagnoses and treatment decisions. In-vitro diagnostics encompass a wide range of tests, including clinical chemistry, immunoassays, molecular diagnostics, hematology, and microbiology. Common examples include blood tests for cholesterol levels, pregnancy tests, and genetic testing. IVD plays a critical role in preventive healthcare, disease screening, and personalized medicine, contributing to early detection and effective management of various medical conditions. The results obtained from in-vitro diagnostic tests help guide patient care and enable healthcare providers to tailor treatment plans based on individual patient needs.
The major global suppliers of In-Vitro Diagnostics include Roche, Abbott, Danaher, Siemens Healthineers, Thermo Fisher Scientific, Sysmex, BioMerieux, Ortho Clinical Diagnostics, Becton Dickinson, Bio-Rad Laboratories, Hologic, LifeScan, Qiagen, Wuhan Easy Diagnosis, Wondfo, KHB, Hotgen, Mindray, Sinocare, Getein Biotech, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of In-Vitro Diagnostics. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global In-Vitro Diagnostics market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the In-Vitro Diagnostics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of In-Vitro Diagnostics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of In-Vitro Diagnostics Include:
Roche
Abbott
Danaher
Siemens Healthineers
Thermo Fisher Scientific
Sysmex
BioMerieux
Ortho Clinical Diagnostics
Becton Dickinson
Bio-Rad Laboratories
Hologic
LifeScan
Qiagen
Wuhan Easy Diagnosis
Wondfo
KHB
Hotgen
Mindray
Sinocare
Getein Biotech
In-Vitro Diagnostics Product Segment Include:
Tissue Diagnostics
Professional Diagnostic
Molecular Diagnostic
Diabetes Monitoring
Others
In-Vitro Diagnostics Product Application Include:
Diabetes
Infectious Diseases
Oncology
Cardiology
HIV
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global In-Vitro Diagnostics Industry PESTEL Analysis
Chapter 3: Global In-Vitro Diagnostics Industry Porter's Five Forces Analysis
Chapter 4: Global In-Vitro Diagnostics Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global In-Vitro Diagnostics Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global In-Vitro Diagnostics Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, In-Vitro Diagnostics Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global In-Vitro Diagnostics market size will reach 77,985 Million USD in 2025 and is projected to reach 106,340 Million USD by 2032, with a CAGR of 4.53% (2025-2032). Notably, the China In-Vitro Diagnostics market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
In-Vitro Diagnostics (IVD) refers to a category of medical tests and diagnostic procedures that are performed on samples such as blood, urine, or tissue outside the body. These tests are designed to provide information about a patient's health status, identify specific diseases or conditions, and aid healthcare professionals in making accurate diagnoses and treatment decisions. In-vitro diagnostics encompass a wide range of tests, including clinical chemistry, immunoassays, molecular diagnostics, hematology, and microbiology. Common examples include blood tests for cholesterol levels, pregnancy tests, and genetic testing. IVD plays a critical role in preventive healthcare, disease screening, and personalized medicine, contributing to early detection and effective management of various medical conditions. The results obtained from in-vitro diagnostic tests help guide patient care and enable healthcare providers to tailor treatment plans based on individual patient needs.
The major global suppliers of In-Vitro Diagnostics include Roche, Abbott, Danaher, Siemens Healthineers, Thermo Fisher Scientific, Sysmex, BioMerieux, Ortho Clinical Diagnostics, Becton Dickinson, Bio-Rad Laboratories, Hologic, LifeScan, Qiagen, Wuhan Easy Diagnosis, Wondfo, KHB, Hotgen, Mindray, Sinocare, Getein Biotech, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of In-Vitro Diagnostics. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global In-Vitro Diagnostics market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the In-Vitro Diagnostics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of In-Vitro Diagnostics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of In-Vitro Diagnostics Include:
Roche
Abbott
Danaher
Siemens Healthineers
Thermo Fisher Scientific
Sysmex
BioMerieux
Ortho Clinical Diagnostics
Becton Dickinson
Bio-Rad Laboratories
Hologic
LifeScan
Qiagen
Wuhan Easy Diagnosis
Wondfo
KHB
Hotgen
Mindray
Sinocare
Getein Biotech
In-Vitro Diagnostics Product Segment Include:
Tissue Diagnostics
Professional Diagnostic
Molecular Diagnostic
Diabetes Monitoring
Others
In-Vitro Diagnostics Product Application Include:
Diabetes
Infectious Diseases
Oncology
Cardiology
HIV
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global In-Vitro Diagnostics Industry PESTEL Analysis
Chapter 3: Global In-Vitro Diagnostics Industry Porter's Five Forces Analysis
Chapter 4: Global In-Vitro Diagnostics Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global In-Vitro Diagnostics Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global In-Vitro Diagnostics Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, In-Vitro Diagnostics Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 In-Vitro Diagnostics Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 In-Vitro Diagnostics Product by Type
- 1.2.1 Tissue Diagnostics
- 1.2.2 Professional Diagnostic
- 1.2.3 Molecular Diagnostic
- 1.2.4 Diabetes Monitoring
- 1.2.5 Others
- 1.3 In-Vitro Diagnostics Product by Application
- 1.3.1 Diabetes
- 1.3.2 Infectious Diseases
- 1.3.3 Oncology
- 1.3.4 Cardiology
- 1.3.5 HIV
- 1.3.6 Other
- 1.4 Global In-Vitro Diagnostics Market Size Analysis (2020-2032)
- 1.5 In-Vitro Diagnostics Market Development Status and Trends
- 1.5.1 In-Vitro Diagnostics Industry Development Status Analysis
- 1.5.2 In-Vitro Diagnostics Industry Development Trends Analysis
- 2 In-Vitro Diagnostics Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 In-Vitro Diagnostics Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global In-Vitro Diagnostics Market Analysis by Country
- 4.1 Global In-Vitro Diagnostics Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global In-Vitro Diagnostics Revenue Analysis by Country (2020-2025)
- 4.1.2 Global In-Vitro Diagnostics Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States In-Vitro Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany In-Vitro Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan In-Vitro Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.5 China In-Vitro Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.6 France In-Vitro Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. In-Vitro Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea In-Vitro Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada In-Vitro Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy In-Vitro Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia In-Vitro Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico In-Vitro Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil In-Vitro Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.14 India In-Vitro Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam In-Vitro Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand In-Vitro Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa In-Vitro Diagnostics Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global In-Vitro Diagnostics Market Revenue by Key Suppliers (2021-2025)
- 5.2 In-Vitro Diagnostics Competitive Landscape Analysis and Market Dynamic
- 5.2.1 In-Vitro Diagnostics Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 In-Vitro Diagnostics Market Analysis by Type
- 6.1 Global In-Vitro Diagnostics Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global In-Vitro Diagnostics Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Roche
- 7.1.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Roche In-Vitro Diagnostics Product Portfolio
- 7.1.3 Roche In-Vitro Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Abbott
- 7.2.1 Abbott Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Abbott In-Vitro Diagnostics Product Portfolio
- 7.2.3 Abbott In-Vitro Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Danaher
- 7.3.1 Danaher Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Danaher In-Vitro Diagnostics Product Portfolio
- 7.3.3 Danaher In-Vitro Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Siemens Healthineers
- 7.4.1 Siemens Healthineers Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Siemens Healthineers In-Vitro Diagnostics Product Portfolio
- 7.4.3 Siemens Healthineers In-Vitro Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Thermo Fisher Scientific
- 7.5.1 Thermo Fisher Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Thermo Fisher Scientific In-Vitro Diagnostics Product Portfolio
- 7.5.3 Thermo Fisher Scientific In-Vitro Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Sysmex
- 7.6.1 Sysmex Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Sysmex In-Vitro Diagnostics Product Portfolio
- 7.6.3 Sysmex In-Vitro Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 BioMerieux
- 7.7.1 BioMerieux Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 BioMerieux In-Vitro Diagnostics Product Portfolio
- 7.7.3 BioMerieux In-Vitro Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Ortho Clinical Diagnostics
- 7.8.1 Ortho Clinical Diagnostics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Ortho Clinical Diagnostics In-Vitro Diagnostics Product Portfolio
- 7.8.3 Ortho Clinical Diagnostics In-Vitro Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Becton Dickinson
- 7.9.1 Becton Dickinson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Becton Dickinson In-Vitro Diagnostics Product Portfolio
- 7.9.3 Becton Dickinson In-Vitro Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Bio-Rad Laboratories
- 7.10.1 Bio-Rad Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Bio-Rad Laboratories In-Vitro Diagnostics Product Portfolio
- 7.10.3 Bio-Rad Laboratories In-Vitro Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 Hologic
- 7.11.1 Hologic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Hologic In-Vitro Diagnostics Product Portfolio
- 7.11.3 Hologic In-Vitro Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.12 LifeScan
- 7.12.1 LifeScan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 LifeScan In-Vitro Diagnostics Product Portfolio
- 7.12.3 LifeScan In-Vitro Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.13 Qiagen
- 7.13.1 Qiagen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.13.2 Qiagen In-Vitro Diagnostics Product Portfolio
- 7.13.3 Qiagen In-Vitro Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.14 Wuhan Easy Diagnosis
- 7.14.1 Wuhan Easy Diagnosis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.14.2 Wuhan Easy Diagnosis In-Vitro Diagnostics Product Portfolio
- 7.14.3 Wuhan Easy Diagnosis In-Vitro Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.15 Wondfo
- 7.15.1 Wondfo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.15.2 Wondfo In-Vitro Diagnostics Product Portfolio
- 7.15.3 Wondfo In-Vitro Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.16 KHB
- 7.16.1 KHB Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.16.2 KHB In-Vitro Diagnostics Product Portfolio
- 7.16.3 KHB In-Vitro Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.17 Hotgen
- 7.17.1 Hotgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.17.2 Hotgen In-Vitro Diagnostics Product Portfolio
- 7.17.3 Hotgen In-Vitro Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.18 Mindray
- 7.18.1 Mindray Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.18.2 Mindray In-Vitro Diagnostics Product Portfolio
- 7.18.3 Mindray In-Vitro Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.19 Sinocare
- 7.19.1 Sinocare Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.19.2 Sinocare In-Vitro Diagnostics Product Portfolio
- 7.19.3 Sinocare In-Vitro Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.20 Getein Biotech
- 7.20.1 Getein Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.20.2 Getein Biotech In-Vitro Diagnostics Product Portfolio
- 7.20.3 Getein Biotech In-Vitro Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 In-Vitro Diagnostics Industry Chain Analysis
- 8.2 In-Vitro Diagnostics Product Downstream Application Analysis
- 8.2.1 Global In-Vitro Diagnostics Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global In-Vitro Diagnostics Revenue and Forecast by Application (2020-2032)
- 8.3 In-Vitro Diagnostics Typical Downstream Customers
- 8.4 In-Vitro Diagnostics Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
